** Shares of Compumedics CMP.AX fall 5% to A$0.285, their biggest intraday pct loss since May 6
** The medical device maker lowers its revenue forecast for FY26 to a range of A$50 million ($32.20 million)- A$55 million, compared to its previous outlook of A$55 million
** Also sees FY26 EBITDA of about A$3 million, lower than earlier forecast of A$5 million
** Co attributes lowered guidance to the lag between reported revenues and sales orders taken for its Somfit device
** YTD, shares up 7.6%
($1 = 1.5528 Australian dollars)
(Reporting by Nichiket Sunil in Bengaluru)
((Nichiket.Sunil@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.